MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 28 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $66,294 | -34.2% | 23,261 | -9.1% | 0.00% | – |
| Q1 2023 | $100,809 | -71.3% | 25,586 | -71.2% | 0.00% | – |
| Q4 2022 | $351,252 | -89.3% | 88,700 | -75.1% | 0.00% | -100.0% |
| Q3 2022 | $3,278,000 | +1862.9% | 356,708 | +1163.4% | 0.00% | – |
| Q2 2022 | $167,000 | +135.2% | 28,233 | +154.4% | 0.00% | – |
| Q1 2022 | $71,000 | -64.1% | 11,100 | -67.9% | 0.00% | – |
| Q3 2021 | $198,000 | -65.8% | 34,600 | -67.1% | 0.00% | – |
| Q2 2021 | $579,000 | +8.0% | 105,200 | +13.6% | 0.00% | – |
| Q1 2021 | $536,000 | +294.1% | 92,600 | +356.4% | 0.00% | – |
| Q4 2020 | $136,000 | – | 20,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
| Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
| ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
| RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
| Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
| Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
| VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
| Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
| Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
| Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |